CompoAtlas

AMMO-8

Natural health product licensed in Canada

Licence holder
Advanced Genetics
NPN or DIN-HM
80051207
Status
Active licence
Licence date
27 May 2014
Revision date
Not provided
Form
Poudre
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
L-Lysine

Source : L-Lysine

600 mgNot calculated
L-Valine

Source : L-valine

500 mgNot calculated
L-Leucine

Source : L-Leucine

1,750 mgNot calculated
L-Isoleucine

Source : L-isoleucine

400 mgNot calculated
L-Thréonine

Source : L-thréonine

500 mgNot calculated

Non-medicinal ingredients

Saveur, Laque d'aluminium FD&C Rouge n° 40, Maltodextrine, Acide citrique, Sucralose, Dioxyde de silicium

PopulationAgeQuantity per servingFrequency
AdultesNot specifiedminimum: 2 Mesures ; maximum: 2 Mesuresminimum: 1 day ; maximum: 1 day

Uses authorised in Canada

Helps to support liver function. A factor in the maintenance of good health. Helps in collagen formation. Source of the essential amino acids histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, valine for the maintenance of good health and involved in protein synthesis. Source of branched chain amino acids to help increase endurance exercise capacity. Athletic support. Workout supplement.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80051207

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line